Data / Research funding / Pennsylvania / Fox Chase Chemical Diversity Center, INC
Fox Chase Chemical Diversity Center, INC: 12 NIH awards ($22.2M), fiscal years 2021 to 2026
Fox Chase Chemical Diversity Center, INC in Doylestown, PA is funded under 12 NIH awards ($22.2M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- V6EQM9ABEM89
- State
- Pennsylvania
Awards
12 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders | NIH | National Institute on Aging | 2021 to 2025 | $7,375,647 | July 1, 2021 | December 31, 2026 | REITZ, ALLEN BERNARD | reporter.nih.gov |
| Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,050,000 | July 20, 2020 | March 31, 2027 | MCDONNELL, MARK E | reporter.nih.gov |
| Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,045,306 | June 1, 2018 | March 31, 2025 | HARTY, RONALD N | reporter.nih.gov |
| Optimizing a Stapled-Peptide That Specifically Targets HSV-1 to Treat Herpes Ocular Keratitis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $3,015,759 | May 1, 2020 | May 31, 2026 | REITZ, ALLEN BERNARD | reporter.nih.gov |
| Development of a Peptide-Drug Conjugate for Topically Treating the Viral Skin Disease Molluscum Contagiosum | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,006,966 | April 19, 2021 | July 31, 2027 | RICCIARDI, ROBERT PAUL | reporter.nih.gov |
| Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT | NIH | National Heart, Lung, and Blood Institute | 2021 | $999,965 | May 15, 2014 | June 30, 2023 | WROBEL, JAY EDWARD | reporter.nih.gov |
| Development of a Peptide-Drug Conjugate for Topically Treating the Viral Skin Disease Molluscum Contagiosum | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $606,500 | April 19, 2021 | March 31, 2024 | RICCIARDI, ROBERT PAUL | reporter.nih.gov |
| Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $598,928 | August 22, 2022 | July 31, 2025 | HARTY, RONALD N | reporter.nih.gov |
| Development of FosA Inhibitors to Potentiate Fosfomycin Activity in Gram-Negative Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $598,124 | August 15, 2022 | June 30, 2024 | WROBEL, JAY EDWARD | reporter.nih.gov |
| Alternative Treatment for Syphilis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $306,500 | November 15, 2024 | November 14, 2025 | SMITHGALL, THOMAS E. | reporter.nih.gov |
| Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $299,999 | July 20, 2020 | April 14, 2023 | MCDONNELL, MARK E | reporter.nih.gov |
| PROTACS Against Nef as a Functional Cure for HIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $297,797 | July 1, 2020 | June 30, 2023 | SMITHGALL, THOMAS E. | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 4 | $3,712,653 | 0 | $0 |
| 2024 | 4 | $4,379,008 | 0 | $0 |
| 2023 | 6 | $5,001,928 | 0 | $0 |
| 2022 | 6 | $4,773,870 | 0 | $0 |
| 2021 | 6 | $4,334,032 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 9 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 9 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 9 awards here |
Topics of its NIH awards
- Infectious Diseases
- Rare Diseases
- Orphan Drug
- Biotechnology
- Translational Research
- Emerging Infectious Diseases
- Biodefense and Related Countermeasures
- Cardiovascular
- Vector-Borne Diseases
- Eye Disease and Disorders of Vision
- Sexually Transmitted Infections
- Hematology
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.